Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.

Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes. SAGE Open Med (2017) 0.75

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50

Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep (1986) 6.04

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep (2003) 4.29

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep (2009) 2.89

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med (2005) 1.42

Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. J Pharmacol Exp Ther (2000) 1.41

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. Br J Clin Pharmacol (2003) 1.40

A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry (1994) 1.32

Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med (2005) 1.19

Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16

Minimal rebound insomnia after treatment with 10-mg zolpidem. Clin Neuropharmacol (1997) 1.01

Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients. J Nerv Ment Dis (2010) 0.98

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol (2011) 0.95

Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: a retrospective assessment of diagnostic and treatment variables. Prim Care Companion J Clin Psychiatry (2010) 0.94

Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep (2012) 0.93

Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. Psychopharmacology (Berl) (1992) 0.92

Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients. J Int Med Res (1991) 0.91

The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J Int Med Res (1992) 0.90

The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev (2004) 0.89

Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. Sleep (2011) 0.88

Long-term follow-up of patients with insomnia. Proc (Bayl Univ Med Cent) (2008) 0.88

Gender differences in highway driving performance after administration of sleep medication: a review of the literature. Traffic Inj Prev (2012) 0.84